FIGURE 4.
Prevalence of MET high in treatment-naïve metastatic NSCLC. Prevalence of MET statuses in treatment-naïve metastatic EGFR-mutant NSCLC.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.